Advertisement
Screener

SELLAS Life Sciences Group, Inc. (SLS) Net Margin

SELLAS Life Sciences Group, Inc. (SLS) Net Margin

  • 2022-03-31: Net Margin -1674.40%.
  • 2021-06-30: Net Margin -242.79%.
  • 2021-03-31: Net Margin -42.16%.
  • 2020-12-31: Net Margin -195.58%.

Complete source-backed net margin history.

Available history
2013-09-30 to 2022-12-31
Data captured

Historical Net Margin

DateNet Margin
2022-03-31-1674.40%
2021-06-30-242.79%
2021-03-31-42.16%
2020-12-31-195.58%
2015-06-30-463.04%
2015-03-31-383.16%
2014-12-31-249.01%
2014-09-30-381.05%
2014-06-30-855.47%
2014-03-31-116.71%
2013-12-31-3682.69%
2013-09-30-793.76%

Annual Net Margin

DateNet Margin
2022-12-31-4130.10%
2021-12-31-272.36%
2020-12-31-881.95%
2014-12-31-392.81%
2013-12-31-3083.15%

Similar stocks

Stock NameCountryMarket CapPE Ratio
uniQure N.V. (QURE)$2.416B-4.93
Vera Therapeutics, Inc. (VERA)United States$2.402B-7.67
Harmony Biosciences Holdings, Inc. (HRMY)United States$2.399B11.67
Nurix Therapeutics, Inc. (NRIX)United States$2.457B-5.39
Mineralys Therapeutics, Inc. (MLYS)United States$2.353B-6.82
Viridian Therapeutics, Inc.\DE (VRDN)United States$2.342B-5.38
SUPERNUS PHARMACEUTICALS, INC. (SUPN)United States$2.517B-24.63
Immunome Inc. (IMNM)United States$2.538B-9.45
Disc Medicine, Inc. (IRON)United States$2.553B-11.40
Zai Lab Ltd (ZLAB)$2.241B-113.34